|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.
|
25923107 |
2015 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study aims to investigate the effects of ARRB1 mediated by miR-29a and miR-652 on liver fibrosis and its possible mechanism.
|
28768954 |
2017 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
This review focuses on the evolving view of the molecular mechanisms by which HSC activation by miR-29a signaling may moderate the profibrogenic phenotype of these cells, thus supporting the use of miR-29a agonists as a potential therapy for treating liver fibrosis in the future.
|
29954104 |
2018 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
We have previously shown that microRNA-29a (miR-29a) protects against liver fibrosis.
|
29105510 |
2018 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
In a previous study, we demonstrated that microRNA-29a (miR-29a) protects against liver fibrosis.
|
29366780 |
2018 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Here, we investigated the role of <i>MicroRNA29a (Mir29a)</i> in the resolution of liver fibrosis.
|
30781750 |
2019 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, we asked whether miR-29a could reduce experimental high fat diet (HFD)-induced obesity and liver fibrosis in mice.
|
31652636 |
2019 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study was conducted to clarify the mechanism of anti-fibrotic effect of miR-29a and to explore if miR-29a is a promising candidate for nucleic acid medicine against liver fibrosis.
|
27480597 |
2016 |
|
Fibrosis, Liver
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The down-regulation of miR-29a and miR-29b in male mouse livers correlated with the early development of liver fibrosis, as indicated by increased expressions of fibrotic markers in male mice relative to female mice.
|
22393047 |
2012 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, the purpose of this study is to investigate the miR-29a regulation of BRD4 signaling in a bile duct-ligation (BDL) animal model with regard to developing cholestatic liver fibrosis.
|
30745801 |
2019 |
|
Fibrosis, Liver
|
0.100 |
Biomarker
|
disease |
BEFREE |
MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
|
28106784 |
2017 |